Insider Transactions

What Upstream Bio, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	5	10
Total trades	5	15

Shares traded

	3 months	12 months
Acquired	0	179,500
Disposed	5,020	10,033
Net activity	−5,020	+169,467

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Deykin Aaron	Chief Medical Officer	Jun 16	Open-market sale · S	−895	$6.10	−$5.46K	33,197
Ambrose Allison	General Counsel	Jun 16	Open-market sale · S	−477	$6.10	−$2.91K	16,048
Houghton Adam	Chief Business Officer	Jun 16	Open-market sale · S	−700	$6.10	−$4.27K	23,601
Sutherland Everett Rand	Chief Executive Officer	Jun 16	Open-market sale · S	−2,095	$6.10	−$12.8K	70,812
Gray Michael	CFO and COO	Jun 16	Open-market sale · S	−853	$6.10	−$5.2K	28,795
Houghton Adam	Chief Business Officer	Mar 16	Open-market sale · S	−699	$9.29	−$6.49K	24,301
Sutherland Everett Rand	Chief Executive Officer	Mar 16	Open-market sale · S	−2,093	$9.29	−$19.4K	72,907
Ambrose Allison	General Counsel	Mar 16	Open-market sale · S	−475	$9.29	−$4.41K	16,525
Deykin Aaron	Chief Medical Officer	Mar 16	Open-market sale · S	−894	$9.29	−$8.31K	32,687
Gray Michael	CFO and COO	Mar 16	Open-market sale · S	−852	$9.29	−$7.92K	29,648
Ambrose Allison	General Counsel	Jan 02	Grant / award · A	+17,000	—	—	17,000
Sutherland Everett Rand	Chief Executive Officer	Jan 02	Grant / award · A	+75,000	—	—	75,000
Houghton Adam	Chief Business Officer	Jan 02	Grant / award · A	+25,000	—	—	25,000
Deykin Aaron	Chief Medical Officer	Jan 02	Grant / award · A	+32,000	—	—	33,581
Gray Michael	CFO and COO	Jan 02	Grant / award · A	+30,500	—	—	30,500
Ai Upstream Llc	10% owner	Oct 15	Derivative Conversion · C	+1,172,410	—	—	5,494,410
Ai Upstream Llc	10% owner	Oct 15	Derivative Conversion · C	+3,147,000	—	—	4,322,000
Ai Upstream Llc	10% owner	Oct 15	Open-market buy · P	+1,175,000	$17.00	+$20M	1,175,000
Wellington Biomedical Innovation Master Investors (Cayman) Ii L.p.	10% owner	Oct 15	Derivative Conversion · C	+894,733	—	—	894,733
Orbimed Advisors Llc	Director	Oct 15	Open-market buy · P	+660,000	$17.00	+$11.2M	4,554,873

Page 1 of 2 · showing the 20 most recent Sign up free to view all 27 transactions and filter by insider →